Varenicline Observational Investigation In The Cessation of Smoking (CHOICES)

Pfizer

Status: Completed

Conditions: Smoking Cessation

Treatments: Drug: Varenicline

Study type: Observational

Funder types: Industry

Identifiers

NCT00669240

A3051085

Details and patient eligibility

About

The purpose of this study is to determine the safety and efficacy of varenicline in the real-world environment of smokers attending primary care in routine clinical practice with the addition of being offered behavioral support "Life REWARDS"TM. This is a non-interventional study.

Full description

Sampling Method Details: Patients as they come to surgeries for smoking cessation treatment.

Enrollment: 567 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patients enrolled should be of legal adult age who regularly smoke and of which the main tobacco product is cigarettes.
• The patients must be willing to make an attempt to stop smoking.

Exclusion criteria

• All patients enrolled should meet the usual prescribing criteria for varenicline as per SmPC and should be entered into the trial at the Investigators discretion.

Trial design

567 participants in 1 patient group

1. Non-interventional

Description:

Patients prescribed varenicline in a non interventional manner.

Treatment:

Drug: Varenicline